Glial Cells in Glaucoma: Friends, Foes, and Potential Therapeutic Targets

Glaucoma is the second leading cause of blindness worldwide, affecting ~80 million people by 2020 (1, 2). The condition is characterized by a progressive loss of retinal ganglion cells (RGCs) and their axons accompanied by visual field loss. The underlying pathophysiology of glaucoma remains elusive...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Bermúdez, Mariana Y., Freude, Kristine K., Mouhammad, Zaynab A., van Wijngaarden, Peter, Martin, Keith K., Kolko, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007906/
https://www.ncbi.nlm.nih.gov/pubmed/33796062
http://dx.doi.org/10.3389/fneur.2021.624983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007906/
https://www.ncbi.nlm.nih.gov/pubmed/33796062
http://dx.doi.org/10.3389/fneur.2021.624983

Ejemplares similares